Technical Information

As new and more potentially active pharmaceutical ingredients (APIs) enter the processing pipeline, protecting workers from hazardous compounds is becoming an increasing concern in the pharmaceutical manufacturing industry. Typically between 5 and 10 percent of commercial available drugs are in the high potency catagory. This number is expected to increase to about 25 percent as more patented small-molecule APIs, currently the fastest growing segment of pharmaceutical research, reach the market.1